Tariffs Won’t Secure Our Drug Supply Chain—They’ll Break It

“Imposing Section 232 tariffs on medicines would worsen shortages, drive up prices, and leave patients with fewer options,” writes Pipes. getty The Trump administration is considering massive “Section 232” tariffs on imported medicines from key U.S. allies, including the European Union, the United Kingdom, Switzerland, Japan, and South Korea. While tariffs on some countries, such…

Read More

This Startup Aims To Grow New Mini-Organs In Patients

In this week’s edition of The Prototype, we look at the U.K.’s first space launch license, growing mini-organs instead of transplanting them, nuclear reactors on the Moon and more. You can sign up to get The Prototype in your inbox here. Skyrora CEO Volodymyr Levykin Sportsfile via Getty Images Glasgow, Scotland-based company Skyrora, which is…

Read More

Revving Up The U.S. Technology Engine

Multiple technology revolutions — digital, AI, biotech, autonomous systems, quantum, precision agriculture — are advancing rapidly, transforming every sector of the economy and national security, and fueling the rise of new industries. Our global competitors are developing and scaling these technologies as fast as they can. More than anything else, winning the challenge to shape…

Read More